Obesity suppresses circulating level and function of endothelial progenitor cells and heart function

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Tsai, Tzu Hsien ^a   Chai, Han Tan ^a   Sun, Cheuk Kwan ^b   Yen, Chia Hung ^c   Leu, Steve ^a   Chen, Yung Lung ^a   Chung, Sheng Ying ^a   Ko, Sheung Fat ^a   Chang, Hsueh Wen ^d   Wu, Chiung Jen ^a   Yip, Hon Kan ^a,e  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Aortic endothelium; Endothelial progenitor cells; Left ventricular remodeling; Obesity

Indexed keywords

ATAXIN 1; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHOLESTEROL; LIPOPOLYSACCHARIDE; NITRIC OXIDE; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ABDOMINAL FAT; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BODY WEIGHT; CELL FUNCTION; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIET RESTRICTION; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM; ENDOTHELIUM CELL; FIBROSIS; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART WEIGHT; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; AORTA; AZO COMPOUNDS; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; ECHOCARDIOGRAPHY; ENDOTHELIAL CELLS; EOSINE YELLOWISH-(YS); EXTREMITIES; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; HEART; HEART FUNCTION TESTS; HEART VENTRICLES; ISCHEMIA; MALE; METHYL GREEN; MICE; MICE, INBRED C57BL; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; OBESITY; STAINING AND LABELING; STEM CELLS; VASODILATION;

EID: 84863088833     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-137     Document Type: Article

References (35)

1. Goodpaster BH, Krishnaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Nevitt M, Holvoet P, Newman AB. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005, 165:777-783.
2. Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Biophys Res Commun 2006, 341:507-514.
3. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
4. Chen H. Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 2006, 53:469-477.
5. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 2007, 10:142-148.
6. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
7. Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young north american men after a 26 year observation period: The manitoba study. Am J Cardiol 1977, 39:452-458.
8. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the framingham heart study. Circulation 1983, 67:968-977.
9. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the united states. JAMA 1999, 282:1530-1538.
10. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002, 105:2696-2698.
11. Eckel RH, Barouch WW, Ershow AG. Report of the national heart, lung, and blood institute-national institute of diabetes and digestive and kidney diseases working group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 2002, 105:2923-2928.
12. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Eng J Med 2006, 355:763-778.
13. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994, 89:36-44.
14. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
15. Yip HK, Hung WC, Yang CH, Chen YH, Cheng CI, Chen SM, Yeh KH. Serum concentrations of high-sensitivity c-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting. Circ J 2005, 69:1202-1207.
16. Orrico C, Pasquinelli G, Foroni L, Muscara D, Tazzari PL, Ricci F, Buzzi M, Baldi E, Muccini N, Gargiulo M, Stella A. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 2010, 40:365-374.
17. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Eng J Med 2005, 353:999-1007.
18. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, Redwood SR, Pearson JD, Marber MS. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004, 109:2986-2992.
19. Valgimigli M, Rigolin GM, Fucili A, Porta MD, Soukhomovskaia O, Malagutti P, Bugli AM, Bragotti LZ, Francolini G, Mauro E, Castoldi G, Ferrari R. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 2004, 110:1209-1212.
20. Chironi G, Walch L, Pernollet MG, Gariepy J, Levenson J, Rendu F, Simon A. Decreased number of circulating cd34 + kdr + cells in asymptomatic subjects with preclinical atherosclerosis. Atherosclerosis 2007, 191:115-120.
21. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
22. Reyes M, Dudek A, Jahagirdar B. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002, 109:337-346.
23. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis HR. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 1997, 99:385-390.
24. Yip HK, Chang LT, Chang WN, Lu CH, Liou CW, Lan MY, Liu JS, Youssef AA, Chang HW. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008, 39:69-74.
25. Chang HW, Leu S, Sun CK, Hang CL, Youssef AA, Hsieh YK, Yang CH, Cheng CI, Chen SM, Chen CJ, Chua S, Chang LT, Wu CJ, Yip HK. Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: In vivo and in vitro studies. Transl Res 2010, 156:251-263.
26. Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, Chua S, Fu M, Yip HK. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009, 37:1197-1205.
27. Yen CH, Lau YT. Vascular responses in male and female hypertensive rats with hyperhomocysteinemia. Hypertension 2002, 40:322-328.
28. Meyers MR, Gokce N. Endothelial dysfunction in obesity: etiological role in atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2007, 14(5):365-369.
29. Campia U, Tesauro M, Cardillo C. Human obesity and endothelium-dependent responsiveness. Br J Pharmacol 2012, 165:561-573.
30. Powell BD, Redfield MM, Bybee KA, Freeman WK, Rihal CS. Association of obesity with left ventricular remodeling and diastolic dysfunction in patients without coronary artery disease. Am J Cardiol 2006, 98:116-120.
31. Chadha DS, Gupta N, Goel K, Pandey RM, Kondal D, Ganjoo RK, Misra A. Impact of obesity on the left ventricular functions and morphology of healthy asian indians. Metab Syndr Relat Disord 2009, 7:151-158.
32. Gong HP, Tan HW, Fang NN, Song T, Li SH, Zhong M, Zhang W, Zhang Y. Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging. Diabetes Res Clin Pract 2009, 83:300-307.
33. Barton M, Baretella O, Meyer MR. Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol 2012, 165:591-602.
34. Martins MA, Catta-Preta M, Mandarim-de-Lacerda CA, Aguila MB, Brunini TC, Mendes-Ribeiro AC. High fat diets modulate nitric oxide biosynthesis and antioxidant defence in red blood cells from c57bl/6 mice. Arch Biochem Biophys 2010, 499:56-61.
35. Md Muhibur R, Zac V, Moorhead John F. Paradoxical increase in nitric oxide synthase activity in hypercholesterolaemic rats with impaired renal function and decreased activity of nitric oxide. Nephrol Dial Transplant 2011, 16:262-268.